Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179036 · ClinicalTrials.gov registry record
Biomagnetic Signals of Intestinal Ischemia II
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT00179036: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00179036 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179036 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2000-01 |
| Est. Completion | 2015-12 |
What the finished NCT00179036 record still lists
NCT00179036 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00179036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179036 about?
NCT00179036 is a clinical study titled "Biomagnetic Signals of Intestinal Ischemia II". The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
What is the current status of trial NCT00179036?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2000-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00179036?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia